Research and Markets - New Trends Reshaping R&D Programs In Pharmaceutical and Biotechnology Industries

Research and Markets (researchandmarkets.com/reports/c9734) has announced the addition of Pharmaceutical R&D Statistical Sourcebook 2004/2005 to their offering.

(PRWEB) November 22, 2004 -- Research and Markets (http://www.researchandmarkets.com/reports/c9734) has announced the addition of Pharmaceutical R&D Statistical Sourcebook 2004/2005 to their offering.

The Pharmaceutical R&D Statistical Sourcebook 2004/2005 provides a comprehensive executive summary on the trends and developments that are reshaping today's R&D programs and the industry itself. This invaluable resource for all professionals working in or with the pharmaceutical and biotechnology industries provides real-world data sets essential for presentations, reports, business development, meetings and analysis.

Contents Include:

Section 1: R&D Spending
- Pharmaceuticals
- Biopharmaceuticals

Section 2: Products in Development
- Pharmaceuticals

Section 3: Drug Development Costs/Complexity, Development Time, and Success Rates
- Costs/Complexity
- Development Time
Section 4: Regulatory/FDA Statistics
- INDs
- NDAs
- Biologics
- Orphan Drugs

Section 5: International Statistics
- European Union
- United Kingdom
- Japan
- Germany
- Canada
- Global

Company profiles are provided for the following Leading Pharmaceutical Companies
GlaxoSmithKline
Biogen Idec
Pfizer
AstraZeneca
Roche
Amgen
Schering-Plough
Merck
Bayer
Sanofi-Synthelabo
Abbott Laboratories
Eli Lilly and Company
Wyeth
Novartis
Aventis
Bristol-Myers Squibb
Johnson & Johnson

Development Project Pipelines are also provided for the following selected Pharma Companies by Therapeutic Category
Sankyo
Chugai
Novo Nordisk
Schering AG
Dainippon
Watson
Yamanouchi
Mylan/Bertek
Takeda
Daiichi
Eisai

For more information visit http://www.researchandmarkets.com/reports/c9734

Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets.com
Fax: +353 1 4100 980

###